Methylprednisolone Completed Phase 2 Trials for Neutropenia / Malignant Lymphomas Supportive Care

IndicationsStatusPurposePhase
CompletedSupportive Care2
clinicaltrials.gov IdentifierTitleDrugs
NCT00004192Colony-Stimulating Factors to Relieve Neutropenia in Patients With Recurrent Non-Hodgkin's Lymphoma